FDA药品溶出方法数据库
(FDA-Recommended Dissolution Methods Database)
药品通用名称 剂型 USP溶出装置 速度 溶出介质 介质体积 建议取样时间(分钟) 更新日期
Nicotine Polacrilex Lozenge I (Basket) 100 Phosphate Buffer, pH 7.4 900 0.5, 1, 2, 3, 6 and 8 hours 2010/12/23
Nicotine Polacrilex Chewing Gum Chewing Machine as desribed in European Pharmacopoeia (2.9.25) 60 cycles (chews) per minute Phosphate Buffer, pH 7.4 or or any other appropriate buffer and conditions 20 5, 10, 20 and 30 2012/01/05
Nifedipine Capsule Refer to USP 2011/03/03
Nifedipine Tablet (Extended Release) Develop a dissolution method 2024/01/03
Nifurtimox Tablet II (Paddle) 100 Acetate Buffer, pH 4.5 with 1.0 % Sodium Dodecyl Sulfate (SDS) (for 30 mg strength) and 1.5 % SDS (for 120 mg strength) 900 10, 20, 30, 60 and 75 2022/07/07
Nifurtimox Tablet II (Paddle) 100 Acetate buffer pH 4.5 with 1% sodium dodecyl sulfate (SDS) for 30 mg strength and 1.5 % SDS for 120 mg strength 900 15, 30, 45, 60, 90 and 120 2023/02/09
Nilotinib HCl Capsule I (Basket) 100 0.1 N HCl 1000 10, 15, 20, 30 and 45 2024/02/05
Nilotinib Hydrochloride Monohydrate Capsule I (Basket) 100 0.1 N HCl 1000 10, 15, 30 and 45 2009/10/30
Nilotinib Tartrate Tablet II (Paddle) 75 pH 6.8 Buffer with 1.25% CTAB 1000 5, 10, 15, 20, 30, 45 and 60 2026/01/28
Nilutamide Tablet Develop a dissolution method 2009/05/20
Nimodipine Capsule Develop a dissolution method 2023/09/15
Nintedanib Esylate Capsule II (Paddle) with sinker 100 0.1 N HCl 900 10, 15, 20, 30, 45 and 60 2015/09/03
Niraparib Capsule II (Paddle) with sinker 50 Tier 1: 0.08M Sodium Acetate Buffer, pH 4.0; Tier 2: 0.08M Sodium Acetate Buffer, pH 4.0 containing pepsin (750,000 units/L) 900 10, 15, 20, 30, 45 and 60 2017/11/02
Niraparib Tosylate Tablet II (Paddle) 60 0.1 M Citrate buffer, pH 4.6 900 5, 10, 15, 20, 25, 30 and 45 2024/02/05
Nirmatrelvir (NIR); Ritonavir (RIT) Tablet (copackage) II (Paddle) 75 NIR: 0.05 M Sodium Phosphate, pH 6.8 with 0.2% Sodium Dodecyl Sulfate; RIT: Refer to USP 900 15, 20, 30, 45 and 60 2024/08/05
Nirogacestat Hydrobromide Tablet II (Paddle) 75 pH 1.2 HCl buffer 500 5, 10, 15, 20, 30, 45 and 60 2025/09/08
Nisoldipine Tablet (Extended Release) II (Paddle) with option to use a sinker 50 HCl with SLS (32.5 ± 0.1 g Sodium Lauryl Sulfate in 6489 mL of purified water containing 17.0 mL HCl, pH adjusted to 1.20 ± 0.05 with HCl) 900 1, 4, 8, 12, 15, 18 and 24 hours 2009/04/02
Nitazoxanide Tablet II (Paddle) 75 Phosphate buffer at pH 7.5 with 6% hexadecyltrimethyl ammonium bromide, bath temperature at 25ºC 900 10, 20, 30, 45, 60 2007/01/03
Nitazoxanide Oral Suspension II (Paddle 100 Phosphate buffer at pH 7.5 with 6% hexadecyltrimethyl ammonium bromide, bath temperature at 25ºC 900 10, 20, 30, 45 and 60 2010/10/21
Nitisinone Capsule II (Paddle) with sinker 50 Phosphate Buffer, pH 6.8 1000 5, 10, 15, 20, 30 and 45 2017/11/02

数据库说明:

当前数据更新日期:2026年04月22日。
©2006-2026 DrugFuture->FDA-Recommended Dissolution Methods Database